We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Serono Sues Cell Genesys Over TKT Gene Activation Patent

Law360 (September 1, 2004, 12:00 AM EDT) -- A subsidiary of Switzerland’s Serono has sued Transkaryotic Therapies (TKT) licensee Cell Genesys, alleging that gene activation technology used in the production of TKT’s biological drugs infringes a U.S. patent....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.